Why Most CBP Gains Are Won or Lost Before Q3

CBP performance is usually decided months before the measure closes. But it rarely feels that way when you’re inside a health plan.

It often turns into a second-half push—closing gaps, launching campaigns, and re-engaging physicians all at once, trying to move the number before year-end. And the results don’t always yield the desired outcome. 

The reality is this: most CBP gains depend on behavior and visibility that happen months before the final reading is captured.

The timing problem hiding inside CBP

CBP is scored on a single reading, which makes it feel like a point-in-time problem.

But that reading is shaped by what happened over months:

• Taking medication consistently
• Daily habits changing in a way that affects blood pressure
• Blood pressure improving enough to stay controlled
• Someone recognizing a problem before the window to act closes

Most of that doesn’t happen in a doctor’s office, it happens between visits. And this is the real opportunity for plans: finding programs that help drive change outside of the office visit.

Why the old CBP playbook never worked 

The environment has changed. There are fewer easy offsets in Stars, more weight on outcomes, and less room for variability.

CBP is one of the clearest ways to influence both Stars performance and total cost of care. It’s tied to real events—strokes, heart attacks, admissions—not just documentation.

But a lot of plans are still managing it like they can make up for it later in the year. That’s the disconnect.

The measure is a snapshot. The risk isn’t.

From the plan’s point of view, most of the signal comes from moments:

• A visit
• A reading
• A chart

Everything else is invisible. But the outcome is decided in that invisible time between visits, when:

• People miss doses
• Side effects are ignored
• Blood pressure creeps up
• Nothing triggers action

I hear this directly from plans: a lot of the strategy still comes down to getting members back into the doctor’s office sooner, so there’s a chance to address medication and blood pressure control. But those are still isolated moments. 

If nothing is happening between visits, you’re relying on those moments to carry most of the outcome.

Why Q4 doesn’t work the way it used to

No one is choosing to wait. Plans are dealing with competing fires, and CBP has to compete with everything else on the list.

But by the time you get to Q4, the math is different. You’re working with a smaller group of members, and they’re the hardest group:

• Harder to reach
• Less likely to respond
• More complex

At the same time:

• Doctors are booked
• Members are tired of outreach
• The window to move the number is closing

And one thing doesn’t change: blood pressure doesn’t fix itself quickly.

If someone hasn’t been taking their medication consistently, or their regimen isn’t working, you can’t fix that in a few weeks. To do this, you need:

• Consistency
• Follow-up
• Time for the body to respond
• A reading that actually captures that change

That takes time and by Q4, you don’t have it. So you push harder, and it still doesn’t move the way you need it to.

What better-performing plans are doing differently

The plans getting ahead of this aren’t doing something magical. They are:

• Looking at performance earlier in the year
• Paying attention to which members are actually drifting
• Adjusting strategy before the number is locked in
• Connecting CBP to cost, not just to a Stars score

And most importantly, they have better visibility into what’s happening between visits. Without that, it’s harder to know who actually needs attention early enough to change the outcome.

When that visibility isn’t there, it often leads to broader outreach:

• Generic reminders
• Untargeted campaigns
• The same intervention for everyone

That’s ineffective and expensive. And it doesn’t move outcomes consistently.

What works is much simpler, and much harder to execute: the right member at the right time with something that actually changes behavior.

The real gap is between visits

Plans already have:

• Care management
• Physician incentives
• Pharmacy data
• Claims

Those are all useful, but they all revolve around events. The real risk builds in the space between those events.

That’s where:

• Someone stops taking their medication regularly
• Their blood pressure starts trending up
• No one sees it
• Nothing changes

We sometimes act like behavior change happens in a 15-minute visit. It doesn’t.

Doctors don’t have the time to walk through daily habits, side effects, or routines. And then the plan sees it later—in the data, the measure, and most importantly, the cost.

Why Q2 is the last window that still works

Q2 is the last point where you still have enough runway for:

• Members to engage
• Physicians to adjust care
• Behavior to stabilize
• Results to show up in a compliant reading

If you act then, you’re working with how the system actually behaves. If you wait, you’re working against it. That’s why most CBP gains are decided before Q3.

Where Hello Heart fits

You likely already know this is an issue in your plan. The challenge is fixing it without adding more work to teams that are already stretched.

We constantly hear plans don’t have a clear, ongoing view of what’s happening between visits—and they don’t have a scalable way to act on it. 

That’s what Hello Heart is built for.

Members use a connected, FDA-cleared blood pressure monitor and app to track readings regularly. That creates ongoing, member-generated data instead of a single point-in-time reading.

From there:

• Members can see how daily habits affect their numbers
• Plans can identify who is trending in the wrong direction earlier
• Care teams have more meaningful data to support follow-up

One plan shared they collected tens of thousands of readings in just a few months—after previously relying on chart retrieval and hoping data showed up.

That’s the difference.

This isn’t about replacing physicians. It’s about extending care into the part of the timeline where most of the outcome is actually determined, and giving plans earlier signals so they can act in time.

The shift to make now

CBP doesn’t get decided at the end of the year. It gets decided in the months before that final reading ever shows up.

The measure is a snapshot, while the risk builds continuously between visits. 

By Q4, you’re not shaping the outcome. You’re trying to recover it. That’s why the most important CBP decisions get made before Q3 begins.

If this is the tension your team is working through, watch this on-demand webinar. 

I joined Dwight Pattison and HAP’s Mark Huizenga to talk through what’s changing in the Stars landscape, why year-round visibility matters more now, and what plans are doing differently to reduce performance surprises.